Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02089295 · ClinicalTrials.gov registry record · Phase 1
Dose Proportionality Study Of PF-00345439 Formulation Under Fed Conditions
A Phase 1 study, sponsored by Pain Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT02089295 is a Phase 1 study that has completed, run by Pain Therapeutics. The registered enrollment target is 18 participants.
The verdict
NCT02089295, a Phase 1 study, has completed, sponsored by Pain Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
To evaluate the dose proportionality of 5 mg, 20 mg and 40 mg of PF 00345439 formulation under fed conditions in healthy volunteers.
Interventions
- DRUG Oxycodone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2014-04 |
| Est. Completion | 2014-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02089295
The ClinicalTrials.gov registry entry for NCT02089295 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pain Therapeutics, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oxycodone is the first listed.
NCT02089295 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02089295 about?
NCT02089295 is a clinical study titled "Dose Proportionality Study Of PF-00345439 Formulation Under Fed Conditions". To evaluate the dose proportionality of 5 mg, 20 mg and 40 mg of PF 00345439 formulation under fed conditions in healthy volunteers.
What is the current status of trial NCT02089295?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2014-04. Estimated completion is 2014-06.
What interventions are being tested in trial NCT02089295?
The interventions under investigation include: Oxycodone (DRUG).
Who is sponsoring clinical trial NCT02089295?
This trial is sponsored by Pain Therapeutics, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.